Bacterial-induced maternal interleukin-17A pathway promotes autistic-like behaviors in mouse offspring.
IL-17A
autism spectrum disorder (ASD)
immunology
lipopolysaccharide (LPS)
maternal immune activation (MIA)
Journal
Experimental animals
ISSN: 1881-7122
Titre abrégé: Exp Anim
Pays: Japan
ID NLM: 9604830
Informations de publication
Date de publication:
24 Apr 2020
24 Apr 2020
Historique:
pubmed:
6
2
2020
medline:
5
8
2020
entrez:
4
2
2020
Statut:
ppublish
Résumé
Maternal immune activation (MIA) by an infection is considered to be an important environmental factor of fetal brain development. Recent animal model on MIA induced by polyinosinic:polycytidylic acid, a mimic of viral infection, demonstrates that maternal IL-17A signaling is required for the development of autism spectrum disorder (ASD)-like behaviors of offspring. However, there is little information on bacterial infection. In this study, we aim to elucidate the influence of MIA induced by lipopolysaccharide (LPS) to mimic a bacterial infection on fetal brain development. We demonstrated that LPS-induced MIA promoted ASD-like behaviors in mouse offspring. We further found that LPS exposure induced acute phase immune response: elevation of serum IL-17A levels in MIA mothers, upregulation of Il17a mRNA expression and increase of IL-17A-producing γδ T cells in the uterus, and upregulation of Il17ra mRNA expression in the fetal brain. Blocking of IL-17A in LPS-induced MIA ameliorated ASD-like behaviors in offspring. Our data suggest that bacterial-induced maternal IL-17A pathway promotes ASD-like behaviors in offspring.
Identifiants
pubmed: 32009087
doi: 10.1538/expanim.19-0156
pmc: PMC7220715
doi:
Substances chimiques
Interleukin-17
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
250-260Références
Nat Immunol. 2009 Dec;10(12):1245-51
pubmed: 19838198
Nat Immunol. 2017 May 18;18(6):604-611
pubmed: 28518154
PLoS One. 2014 Aug 11;9(8):e104433
pubmed: 25111339
Nat Immunol. 2015 Apr;16(4):328-34
pubmed: 25789673
Nat Immunol. 2017 May 18;18(6):612-621
pubmed: 28518156
Nature. 2017 Sep 28;549(7673):528-532
pubmed: 28902840
Science. 2016 Aug 19;353(6301):772-7
pubmed: 27540164
Biol Psychiatry. 2014 Feb 15;75(4):307-15
pubmed: 23938317
J Immunol. 2007 Apr 1;178(7):4466-72
pubmed: 17372004
J Reprod Immunol. 2019 Feb;131:57-62
pubmed: 30710888
J Immunol. 2018 Aug 1;201(3):845-850
pubmed: 29967099
Science. 2016 Feb 26;351(6276):933-9
pubmed: 26822608
Neurotoxicology. 2007 Sep;28(5):931-7
pubmed: 17368774
J Autism Dev Disord. 2012 Jul;42(7):1304-13
pubmed: 21947663
Curr Opin Neurol. 2013 Apr;26(2):146-53
pubmed: 23406909
Immunol Cell Biol. 2016 Aug;94(7):623-30
pubmed: 27241697
Semin Immunol. 1998 Oct;10(5):351-3
pubmed: 9799709
J Exp Med. 2008 Jun 9;205(6):1381-93
pubmed: 18504307
Am J Med Genet B Neuropsychiatr Genet. 2012 Jan;159B(1):5-12
pubmed: 22095612
Nat Immunol. 2008 Jun;9(6):641-9
pubmed: 18454151
Immunity. 1995 Dec;3(6):811-21
pubmed: 8777726
Immunology. 2018 Dec;155(4):418-426
pubmed: 30133701
Nature. 2017 Sep 28;549(7673):482-487
pubmed: 28902835
J Neurosci Res. 2012 Oct;90(10):1903-12
pubmed: 22714803
Brain Behav Immun. 2012 May;26(4):623-34
pubmed: 22310921
J Autism Dev Disord. 2012 Dec;42(12):2585-96
pubmed: 22453928
Res Dev Disabil. 2011 Nov-Dec;32(6):2346-51
pubmed: 21824745
J Immunol. 2006 Jul 1;177(1):36-9
pubmed: 16785495
Clin Transl Immunology. 2018 Jan 29;7(1):e1008
pubmed: 29484185
Exp Neurol. 2018 Jan;299(Pt A):228-240
pubmed: 28455196
J Autism Dev Disord. 2010 Dec;40(12):1423-30
pubmed: 20414802
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136